Examining Issues Related to Competition in the Pharmaceutical Market Place: a Review of the FTC Report, Generic Drug Entry Prior to Patent Expiration : Congressional Hearing

Hearing on whether innovator drug companies may be using questionable tactics to delay the entry of generic competitors. Witnesses: Mark A. Barondess; Lester M. Crawford, Acting Commr., & Daniel D. Troy, Chief Counsel, Food & Drug Admin. (FDA); Gregory J. Glover, Ropes & Tray, on behalf of PhRMA; Kathleen D. Jaeger, Pres. & CEO, Generic Pharmaceutical Assoc.; Sharon Levine, Assoc. Exec. Dir., the Permanente Medical Group, on behalf of RxHealthValue; & Timothy J. Muris, Chmn., Fed. Trade Comm. (FTC).Bilirakis, Michael is the author of 'Examining Issues Related to Competition in the Pharmaceutical Market Place: a Review of the FTC Report, Generic Drug Entry Prior to Patent Expiration : Congressional Hearing', published 2004 under ISBN 9780756742195 and ISBN 0756742196.